Midodrine Tillomed (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Tillomed, is a Alpha-1 adrenergic agonist presented as an oral dosage form for oral use. It raises blood pressure in patients with orthostatic hypotension, helping to prevent dizziness and fainting when standing.

GNH USA supplies Midodrine Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine is an antihypotensive agent that acts on the autonomic regulation of blood pressure. It is primarily used for conditions characterized by insufficient standing blood pressure.

- Orthostatic hypotension: improves standing systolic pressure and reduces dizziness. - Postural hypotension: prevents symptom recurrence after positional changes. - Neurogenic orthostatic hypotension: supports patients with autonomic failure by increasing vascular tone.

Midodrine may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Piloerection: localized goose‑flesh skin reaction. - Pruritus: itching, often on the torso. - Urinary retention: difficulty emptying the bladder. - Supine hypertension: elevated blood pressure when lying down. - Headache: mild to moderate intensity. - Gastrointestinal discomfort: nausea or abdominal cramps.

Serious or Rare Side Effects: - Severe hypertension: marked rise in blood pressure requiring medical intervention. - Bradycardia: unusually slow heart rate. - Allergic reactions: rash, hives, or swelling. - Angioedema: rapid swelling of face, lips, or throat. - Myocardial ischemia: chest pain due to reduced heart blood flow. - Thromboembolic events: rare clot formation.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Blood pressure monitoring: check supine and standing readings regularly. - Supine positioning: advise patients to avoid lying flat for at least 4 hours after dosing. - Renal impairment: adjust dose or monitor closely in reduced kidney function. - Concomitant antihypertensives: assess for additive blood‑pressure lowering effects. - Urinary retention: observe for signs of bladder dysfunction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Midodrine can interact with several drug classes, influencing its efficacy and safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of excessive vasoconstriction. - Other alpha‑1 agonists: additive hypertensive effect. - Tricyclic antidepressants: may potentiate blood‑pressure rise. - Clonidine withdrawal: sudden increase in blood pressure.

Moderate Interactions (Monitor Closely): - Diuretics: may amplify orthostatic changes. - Antihypertensive agents: require dose adjustments. - Beta‑blockers: possible blunted heart‑rate response. - SSRIs and SNRIs: monitor for hypertension. - NSAIDs: may affect renal handling of the drug.